Coherus BioSciences Inc (CHRS)

NASDAQ
14.15
-0.23(-1.60%)
After Hours
14.00
-0.15(-1.06%)
- Real-time Data
  • Volume:
    1,260,048
  • Bid/Ask:
    14.00/14.74
  • Day's Range:
    14.06 - 14.48

CHRS Overview

Prev. Close
14.15
Day's Range
14.06-14.48
Revenue
442.67M
Open
14.48
52 wk Range
12.91-22.22
EPS
-1.24
Volume
1,260,048
Market Cap
1.07B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
858,537
P/E Ratio
-
Beta
1.05
1-Year Change
-18.26%
Shares Outstanding
75,752,478
Next Earnings Date
Aug 11, 2021
What is your sentiment on Coherus BioSciences Inc?
or
Market is currently closed. Voting is open during market hours.

Coherus BioSciences Inc News

Coherus BioSciences Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellSellStrong Sell
Technical IndicatorsStrong BuyStrong SellStrong SellStrong BuyStrong Sell
SummaryBuyStrong SellStrong SellNeutralStrong Sell

Coherus BioSciences Inc Company Profile

Coherus BioSciences Inc Company Profile

Employees
310

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline includes biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar; and CHS-131, a once-daily oral drug candidate for non-alcoholic steatohepatitis and other metabolic conditions. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Read More
  • great potential for this small company
    0
    • SimplyWall.st gives a PT of 95$. Could not be more bullish
      0
      • why its going down?
        0
        • time to go up
          0
          • i think this level has been warded off enough now to prove the resilience of the stock
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.